DLB insider files Form 144 to sell 3,000 common shares

An insider of DLB has filed a Form 144 indicating an intent to sell up to 3,000 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of 196,650.00.

Rhea-AI Filing Summary

An insider of DLB has filed a Form 144 indicating an intent to sell up to 3,000 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of 196,650.00. The shares relate to restricted stock awards acquired from the issuer on 05/16/2023 and 05/16/2024, totaling 2,279 and 721 shares respectively, both noted as not involving special payment terms. The notice lists 60,845,846 shares of the issuer’s common stock outstanding and targets an approximate sale date of 11/21/2025 on the NYSE. Over the prior three months, the same seller disposed of 7,000 shares of common stock on 08/22/2025 for gross proceeds of 524,440.00.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for DLB disclose about planned share sales?

The Form 144 shows an insider plans to sell up to 3,000 shares of DLB common stock through Morgan Stanley Smith Barney, with an aggregate market value of 196,650.00. The approximate sale date disclosed is 11/21/2025 on the NYSE.

How many DLB shares are reported as outstanding in this Form 144?

The notice states that the issuer has 60,845,846 shares of common stock outstanding. This figure provides context for the relative size of the 3,000-share planned sale.

What prior DLB share sales by the insider are reported in the last 3 months?

The filing reports that Shriram Revankar, located in San Francisco, sold 7,000 shares of DLB common stock on 08/22/2025, generating gross proceeds of 524,440.00.

How did the insider acquire the DLB shares being sold under this Form 144?

The shares were acquired as restricted stock from the issuer. One grant of 2,279 shares was acquired on 05/16/2023 and another of 721 shares on 05/16/2024, both with payment described as Not Applicable.

Which broker is handling the planned Form 144 sale for DLB shares?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as the broker for the planned sale of 3,000 shares of DLB common stock.

What representation does the insider make about information on the issuer in this DLB Form 144?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/21/2025 - 04:07 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001928994
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	DOLBY LABORATORIES, INC.
SEC File Number	001-32431
Address of Issuer	1275 Market Street San Francisco CALIFORNIA 94103-1410
Phone	(415) 558-0200
Name of Person for Whose Account the Securities are To Be Sold	SHRIRAM REVANKAR
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3000	196650.00	60845846	11/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/16/2023	Restricted Stock	ISSUER			2279	05/16/2023	Not Applicable
Common	05/16/2024	Restricted Stock	ISSUER			721	05/16/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
SHRIRAM REVANKAR 1275 Market Street San Francisco CA 94103-1410	Common	08/22/2025	7000	524440.00

144: Remarks and Signature

Remarks
Date of Notice	11/21/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/22/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Shriram Revankar
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)